Quadrant Capital Group’s Celldex Therapeutics CLDX Stock Holding History

Quadrant Capital Group’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.14K	Buy
2025 Q2	–	Sell
2025 Q1	$6.06K	Buy
2024 Q4	$1.69K	Buy
2022 Q3	–	Sell
2022 Q2	$4K	Buy
2016 Q1	–	Sell
2015 Q4	$5K	Buy